Clinical Trial Update: Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy and safety of recombinant human thrombopoietin (rhTPO) for chemotherapy-induced thrombocytopenia in patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Thrombocytopenia

Drugs mentioned

• rhTPO (recombinant human thrombopoietin)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Thrombocytopenia | Phase 4 | Status: COMPLETED